Janice S. Sung

Janice S. Sung

Auto-generated profile, based on publicly available information

Janice S. Sung

Department of Radiology, Memorial Sloan Kettering Cancer Center, 300 E 66th St, New York, NY 10065

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2013 in Radiology
Verified
Journal Article
Closed access
MJMaxine Jochelson
Maxine Jochelson
DDD. David Dershaw
D. David Dershaw
JSJanice S. Sung
Janice S. Sung
AHAlexandra S. Heerdt
Alexandra S. Heerdt
CTCynthia Thornton
Cynthia Thornton
EMElizabeth A. Morris
Elizabeth A. Morris
To determine feasibility of performing bilateral dual-energy (DE) contrast agent-enhanced (CE) digital mammography and to evaluate its performance compared with conventional digital mammography and breast magnetic resonance (MR) imaging in women with known breast cancer. This study was approved by the institutional review board and was HIPAA compliant. Written informed consent was obtained. Patient accrual began in March 2010 and ended in August 2011. Mean patient age was 49.6 years (range, 25-74 years). Feasibility was evaluated in 10 women with newly diagnosed breast cancer who were injected with 1.5 mL per kilogram of body weight of iohexol and imaged between 2.5 and 10 minutes after injection. Once feasibility was confirmed, 52 women with newly diagnosed cancer who had undergone breast MR imaging gave consent to undergo DE CE digital mammography. Positive findings were confirmed with pathologic findings. Feasibility was confirmed with no adverse events. Visualization of tumor enhancement was independent of timing after contrast agent injection for up to 10 minutes. MR imaging and DE CE digital mammography both depicted 50 (96%) of 52 index tumors; conventional mammography depicted 42 (81%). Lesions depicted by using DE CE digital mammography ranged from 4 to 67 mm in size (median, 17 mm). DE CE digital mammography depicted 14 (56%) of 25 additional ipsilateral cancers compared with 22 (88%) of 25 for MR imaging. There were two false-positive findings with DE CE digital mammography and 13 false-positive findings with MR imaging. There was one contralateral cancer, which was not evident with either modality. Bilateral DE CE digital mammography was feasible and easily accomplished. It was used to detect known primary tumors at a rate comparable to that of MR imaging and higher than that of conventional digital mammography. DE CE digital mammography had a lower sensitivity for detecting additional ipsilateral cancers than did MR imaging, but the specificity was higher. © RSNA, 2012.

1 October 2019 in Radiology
Verified
Journal Article
Closed access
JSJanice S. Sung
Janice S. Sung
LLLizza Lebron
Lizza Lebron
DKDelia Keating
Delia Keating
DDDonna D’aLessio
Donna D’aLessio
CCChristopher E. Comstock
Christopher E. Comstock
MJMaxine Jochelson
Maxine Jochelson
For screening women at increased risk for breast cancer, the sensitivity of contrast agent–enhanced mammography was 87.5%, compared with 50.0% for digital mammography (P = .03), with a specificity ... BackgroundContrast agent–enhanced digital mammography (CEDM) has been shown to be more sensitive and specific than two-dimensional full-field digital mammography in the diagnostic setting. Few stud...

1 August 2014 in European Journal of Radiology
Verified
Journal Article
Closed access
MFMark A. Francescone
Mark A. Francescone
MJMaxine Jochelson
Maxine Jochelson
DDD. David Dershaw
D. David Dershaw
JSJanice S. Sung
Janice S. Sung
MHMary C. Hughes
Mary C. Hughes
EMElizabeth A. Morris
Elizabeth A. Morris

1 September 2016 in Radiology
Verified
Journal Article
Closed access
JSJanice S. Sung
Janice S. Sung
SSSarah Stamler
Sarah Stamler
JBJennifer Brooks
Jennifer Brooks
JKJennifer Kaplan
Jennifer Kaplan
THTammy Huang
Tammy Huang
CCChristopher E. Comstock
Christopher E. Comstock
In a screening program combining annual MR imaging and mammography in women at high risk of cancer, invasive cancer was more likely to be detected at breast MR imaging, 28 of 43(65%) cancers detect... PurposeTo compare the clinical, imaging, and histopathologic features of breast cancers detected at screening magnetic resonance (MR) imaging, screening mammography, and those detected between scre...

1 June 2014 in American Journal of Roentgenology
Verified
Journal Article
Closed access
JSJanice S. Sung
Janice S. Sung
JLJie Li
Jie Li
GCGlenys Da Costa
Glenys Da Costa
SPSujata Patil
Sujata Patil
KZKimberly J. Van Zee
Kimberly J. Van Zee
EMElizabeth A. Morris
Elizabeth A. Morris
The purpose of this study was to evaluate the effect of the use of preoperative breast MRI on surgical and long-term outcomes among women with early-stage breast cancer undergoing breast conservation therapy. A retrospective review yielded the cases of 174 women with stage 0, I, or II breast cancer who underwent preoperative MRI between 2000 and 2004. A control group of 174 patients who did not undergo preoperative MRI before breast conservation therapy was matched by age, histopathologic finding, stage, and surgeon. Features compared included breast density, presence of mammographically occult disease, margin status, lymph node involvement, lymphovascular invasion, extensive intraductal component, hormone receptor status, and use of adjuvant therapy. Outcomes, including rates of reexcision, ipsilateral recurrence, and disease-free survival, were compared by Kaplan-Meier methods and the log-rank test. Patients referred for preoperative breast MRI were more likely to have extremely dense breasts (28% vs 6%, p < 0.0001) and mammographically occult cancer (24% vs 9%, p = 0.0003). The two groups had identical rates of final negative margins, lymph node involvement, lymphovascular invasion, extensive intraductal component status, positive hormone receptor results, and systemic adjuvant therapy. Fewer patients in the preoperative MRI group needed reexcision (29% vs 45%, p = 0.02). The median follow-up period after treatment was 8 years. There was no significant difference in locoregional recurrence (p = 0.33) or disease-free survival (p = 0.73) rates between the two groups. Reexcision rates among patients with early breast cancer undergoing conservation therapy were lower among women who underwent preoperative breast MRI. There was no statistically significant effect of the use of preoperative MRI on rates of locoregional recurrence or disease-free survival.

1 August 2013 in Magnetic Resonance Imaging Clinics of North America
Verified
Journal Article
Closed access
CCChristopher Comstock
Christopher Comstock
JSJanice S. Sung
Janice S. Sung